<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38831890</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2213-4220</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Integrative medicine research</Title><ISOAbbreviation>Integr Med Res</ISOAbbreviation></Journal><ArticleTitle>Traditional Chinese medicine for post-viral olfactory dysfunction: A systematic review.</ArticleTitle><Pagination><StartPage>101045</StartPage><MedlinePgn>101045</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101045</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.imr.2024.101045</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Post-viral olfactory dysfunction (PVOD) is the common symptoms of long COVID, lacking of effective treatments. Traditional Chinese medicine (TCM) is claimed to be effective in treating olfactory dysfunction, but the evidence has not yet been critically appraised. We conducted a systematic review to evaluate the effectiveness and safety of TCM for PVOD.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We searched eight databases to identified clinical controlled studies about TCM for PVOD. The Cochrane risk of bias tools and GRADE were used to evaluate the quality of evidence. Risk ratio (RR), mean differences (MD), and 95 % confidence interval (CI), were used for effect estimation and RevMan 5.4.1 was used for data analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Six randomized controlled trials (RCTs) (545 participants), two non-randomized controlled trials (non-RCTs) (112 participants), and one retrospective cohort study (30 participants) were included. The overall quality of included studies was low. Acupuncture (<i>n</i> = 8) and acupoint injection (<i>n</i> = 3) were the mainly used TCM therapies. Five RCTs showed a better effect in TCM group. Four trials used acupuncture, and three trials used acupoint injection. The results of two non-RCTs and one cohort study were not statistically significant. Two trials reported mild to moderate adverse events (pain and brief syncope caused by acupuncture or acupoint injection).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Limited evidence focus on acupuncture and acupoint injection for PVOD and suggests that acupuncture and acupoint injection may be effective in improving PVOD. More well-designed trials should focus on acupuncture to confirm the benefit.</AbstractText><AbstractText Label="PROTOCOL REGISTRATION" NlmCategory="UNASSIGNED">The protocol of this review was registered at PROSPERO: CRD42022366776.</AbstractText><CopyrightInformation>&#xa9; 2024 Korea Institute of Oriental Medicine. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Xiang-Yun</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gastroenterology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xue-Han</ForeName><Initials>XH</Initials><AffiliationInfo><Affiliation>Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Chun-Li</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Guangdong Pharmaceutical University, 280 Huandong Road, University Town, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jin</LastName><ForeName>Xin-Yan</ForeName><Initials>XY</Initials><AffiliationInfo><Affiliation>Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Bai-Xiang</ForeName><Initials>BX</Initials><AffiliationInfo><Affiliation>Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Gastroenterology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Yi-Lei</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guanganmen Hospital, Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Hospital of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Yi-Dan</ForeName><Initials>YD</Initials><AffiliationInfo><Affiliation>Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Hospital of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qi</LastName><ForeName>Shi-Hao</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheng</LastName><ForeName>Zhu-Jun</ForeName><Initials>ZJ</Initials><AffiliationInfo><Affiliation>Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Zhan-Feng</ForeName><Initials>ZF</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Guo-Yan</ForeName><Initials>GY</Initials><AffiliationInfo><Affiliation>NICM Health Research Institute, Western Sydney University, Penrith, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stub</LastName><ForeName>Trine</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>The National Research Center in Complementary and Alternative Medicine (NAFKAM), Department of Community Medicine, Faculty of Health Science, UiT The Arctic University of Norway, Troms&#xf8;, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jian-Ping</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The National Research Center in Complementary and Alternative Medicine (NAFKAM), Department of Community Medicine, Faculty of Health Science, UiT The Arctic University of Norway, Troms&#xf8;, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Integr Med Res</MedlineTA><NlmUniqueID>101612707</NlmUniqueID><ISSNLinking>2213-4220</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acupuncture</Keyword><Keyword MajorTopicYN="N">Anosmia</Keyword><Keyword MajorTopicYN="N">Hyposmia</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-viral olfactory dysfunction</Keyword></KeywordList><CoiStatement>The author JPL is senior editorial board member of the journal, but none of the authors has any conflict of interest regarding this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>4</Day><Hour>3</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38831890</ArticleId><ArticleId IdType="pmc">PMC11144739</ArticleId><ArticleId IdType="doi">10.1016/j.imr.2024.101045</ArticleId><ArticleId IdType="pii">S2213-4220(24)00025-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard, &lt;https://covid19.who.int&gt; 2023. Accessed April 23, 2023.</Citation></Reference><Reference><Citation>Ramakrishnan R.K., Kashour T., Hamid Q., Halwani R., Tleyjeh I.M. Unraveling the mystery surrounding post-acute sequelae of COVID-19. Front Immunol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8278217</ArticleId><ArticleId IdType="pubmed">34276671</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Bluemke D.A., L&#xfc;scher T.F., Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43(11):1157&#x2013;1172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>(WHO) WHO. 2023. Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic, &lt;https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-%282005%29-emergency-committee-regarding-the-coronavirus-disease-%28covid-19%29-pandemic&gt;. Accessed May 5, 2023.</Citation></Reference><Reference><Citation>Kapoor D., Verma N., Gupta N., Goyal A. Post viral olfactory dysfunction after SARS-CoV-2 infection: anticipated post-pandemic clinical challenge. Indian J Otolaryngol Head Neck Surg. 2022;74(S3):4571&#x2013;4578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8260324</ArticleId><ArticleId IdType="pubmed">34249668</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Yao Q., Gu X., Wang Q., Ren L., Wang Y., et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xf8;lstad I., Dahlslett S.B., Bachmann-Harildstad G., Steinsv&#xe5;g S. Changed sense of smell - what can be done? Tidsskr Nor Laegeforen. 2022;142(8)</Citation><ArticleIdList><ArticleId IdType="pubmed">35635426</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinidis I., Haehner A., Frasnelli J., Reden J., Quante G., Damm M., et al. Post-infectious olfactory dysfunction exhibits a seasonal pattern. Rhinology. 2006;44(2):135&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">16792173</ArticleId></ArticleIdList></Reference><Reference><Citation>CJoOHaNSEBR Group. Expert consensus on diagnosis and treatment of olfactory dysfunction (2017) Chin J Otorhinolaryngol Head Neck Surg. 2018;53(7):484&#x2013;494.</Citation><ArticleIdList><ArticleId IdType="pubmed">30032490</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.J., Gupta S., Kallogjeri D., Piccirillo J.F. Safety of high-dose nasal theophylline irrigation in the treatment of postviral olfactory dysfunction: a dose-escalation study. JAMA Otolaryngol&#x2013;Head Neck Surg. 2022;148(9):885&#x2013;886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9264213</ArticleId><ArticleId IdType="pubmed">35797023</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiramongkolchai P., Jones M.S., Peterson A., Lee J.J., Liebendorfer A., Klatt-Cromwell C.N., et al. Association of olfactory training with neural connectivity in adults with postviral olfactory dysfunction. JAMA Otolaryngol&#x2013;Head Neck Surg. 2021;147(6):502&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7974830</ArticleId><ArticleId IdType="pubmed">33734298</ArticleId></ArticleIdList></Reference><Reference><Citation>Hura N., Xie D.X., Choby G.W., Schlosser R.J., Orlov C.P., Seal S.M., et al. Treatment of post-viral olfactory dysfunction: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2020;10(9):1065&#x2013;1086.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361320</ArticleId><ArticleId IdType="pubmed">32567798</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y., Shi L., Zhang S., Xiang Q. TCM treatment of olfactory disorders after virus infection. Chin J Otorhinolaryngol Integr Med. 2018;26(06):427&#x2013;430.</Citation></Reference><Reference><Citation>Hashem-Dabaghian F., Ali Azimi S., Bahrami M., Latifi S.A., Enayati A., Qaraaty M. Effect of Lavender (Lavandula angustifolia L.) syrup on olfactory dysfunction in COVID-19 infection: a pilot controlled clinical trial. Avicenna J Phytomed. 2022;12(1):1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8801216</ArticleId><ArticleId IdType="pubmed">35145890</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu T.J., Yu A.C., Lee J.T. Management of post-COVID-19 olfactory dysfunction. Curr Treat Options Allergy. 2022;9(1):1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8723803</ArticleId><ArticleId IdType="pubmed">35004126</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Altman D.G., G&#xf8;tzsche P.C., J&#xfc;ni P., Moher D., Oxman A.D., et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne J.A., Hern&#xe1;n M.A., Reeves B.C., Savovi&#x107; J., Berkman N.D., Viswanathan M., et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>Ottawa Hospital Research Institute, 2022 &lt;https://www.ohri.ca//programs/clinical_epidemiology/oxford.asp&gt;. Accessed October 27, 2022.</Citation></Reference><Reference><Citation>Guyatt G., Oxman A.D., Akl E.A., Kunz R., Vist G., Brozek J., et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383&#x2013;394.</Citation><ArticleIdList><ArticleId IdType="pubmed">21195583</ArticleId></ArticleIdList></Reference><Reference><Citation>Drews T., Hummel T., Rochlitzer B., Hauswald B., H&#xe4;hner A. Acupuncture is associated with a positive effect on odour discrimination in patients with postinfectious smell loss-a controlled prospective study. Eur Arch Otorhinolaryngol. 2022;279(3):1329&#x2013;1334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8897321</ArticleId><ArticleId IdType="pubmed">34032906</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang Z.H., Yu H.M., Dai Q. Therapeutic effect of acupuncture and acupoint injection on the condition of postvirus-infectiong olfactory dysfunction. Chin J Otorhinolaryngol Integr Med. 2016;24(1):23&#x2013;26.</Citation></Reference><Reference><Citation>Ma X.J., Feng H. Clinical study of acupuncture combined with acupoint injection in the treatment of olfactory disorder after virus infection. Modern J Integr Tradit Chin Western Med. 2020;29(31):3492&#x2013;3495.</Citation></Reference><Reference><Citation>Wang M., WANG C., DING Y., WANG L.H., HU R., ZHANG J.J., et al. Comparative study on the clinical synergism of Tiantu and Yingxiang acupoint injection for post-viral olfactory dysfunction. Chin J Otorhinolaryngol Integr Med. 2020;28(4):266&#x2013;271.</Citation></Reference><Reference><Citation>Dai Q., Pang Z., Yu H. Recovery of olfactory function in postviral olfactory dysfunction patients after acupuncture treatment. Evid Based Complement Alternat Med. 2016;2016</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4789421</ArticleId><ArticleId IdType="pubmed">27034689</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H.Q., Li M., lQ Gu. Observation on the effect of combination of traditional Chinese and western medicine in the treatment of post-viral olfactory dysfunction. Chin Primary Health Care. 2018;32(10):69&#x2013;71.</Citation></Reference><Reference><Citation>Vent J., Wang D.W., Damm M. Effects of traditional Chinese acupuncture in post-viral olfactory dysfunction. Otolaryngol Head Neck Surg. 2010;142(4):505&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pubmed">20304268</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X.M., Zheng L., Bai S. Clinical efficacy of intranasal acupuncture in the treatment of olfactory disorder after virus infection and its effect on the expression level of Toll like receptor 3 and inflammatory immune response. J Chin Tradit Med. 2022:1&#x2013;12.</Citation></Reference><Reference><Citation>Ding X.M., Zhang H., Kong F., Bai S. Combination of acupuncture and medicine in treatment of postviral olfactory dysfunction through TLR4/MyD88/NF-&#x3ba;B signaling pathway. China J Modern Med. 2022;32(17):1&#x2013;7.</Citation></Reference><Reference><Citation>Xydakis M.S., Albers M.W., Holbrook E.H., Lyon D.M., Shih R.Y., Frasnelli J.A., et al. Post-viral effects of COVID-19 in the olfactory system and their implications. Lancet Neurol. 2021;20(9):753&#x2013;761.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8324113</ArticleId><ArticleId IdType="pubmed">34339626</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu M.Q., Hu H.T., Hu R.J., Fang J.Q. [Clinical application and mechanism exploration on dysosmia treated with acupuncture and moxibustion] Zhongguo Zhen Jiu. 2020;40(4):425&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pubmed">32275374</ArticleId></ArticleIdList></Reference><Reference><Citation>Helman S.N., Adler J., Jafari A., Bennett S., Vuncannon J.R., Cozart A.C., et al. Treatment strategies for postviral olfactory dysfunction: a systematic review. Allergy Asthma Proc. 2022;43(2):96&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8984764</ArticleId><ArticleId IdType="pubmed">35317886</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma F., Zhang H., Li B., Yang D., Cheng P., Yu M., et al. The effect of traditional Chinese medicine on postviral olfactory dysfunction: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2023;2023</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9876686</ArticleId><ArticleId IdType="pubmed">36714533</ArticleId></ArticleIdList></Reference><Reference><Citation>CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials, &lt;https://www.equator-network.org/reporting-guidelines/consort/&gt;; Accessed October 30, 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2857832</ArticleId><ArticleId IdType="pubmed">20334632</ArticleId></ArticleIdList></Reference><Reference><Citation>Revised standards for reporting interventions in clinical trials of acupuncture (STRICTA): extending the CONSORT statement | The EQUATOR network, &lt;https://www.equator-network.org/reporting-guidelines/consort-stricta/&gt;. Accessed October 30, 2023.</Citation></Reference><Reference><Citation>Mehraeen E., Behnezhad F., Salehi M.A., Noori T., Harandi H., SeyedAlinaghi S. Olfactory and gustatory dysfunctions due to the coronavirus disease (COVID-19): a review of current evidence. Eur Arch Otorhinolaryngol. 2021;278(2):307&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7297932</ArticleId><ArticleId IdType="pubmed">32556781</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>